PARP inhibitors (Cycle Pharmaceuticals/University of Cambridge/King’s College London)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NamePARP inhibitors (Cycle Pharmaceuticals/University of Cambridge/King’s College London)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPoly (ADP-Ribose) polymerase inhibitors
TargetsPoly (ADP-Ribose) polymerase
Therapy Area/IndicationsVascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Cambridge
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsVascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A